Canopy Growth Corporation (CGC)

$0.618

+0.06 (+10.36%)
Rating:
Recommendation:
-
Symbol CGC
Price $0.618
Beta 2.186
Volume Avg. 50.26M
Market Cap 512.374M
Shares () -
52 Week Range 0.346-4.77
1y Target Est -
DCF Unlevered CGC DCF ->
DCF Levered CGC LDCF ->
ROE -133.62% Strong Sell
ROA -75.68% Strong Sell
Operating Margin -
Debt / Equity 102.11% Buy
P/E -0.40 Neutral
P/B 0.59 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest CGC news


Mr. David Eric Klein
Healthcare
Drug Manufacturers—Specialty & Generic
NASDAQ Global Select

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.